logo
Hidden costs of cancer for young survivors is derailing their financial futures

Hidden costs of cancer for young survivors is derailing their financial futures

News182 days ago
Toronto, Aug 17 (The Conversation) Imagine being 25, fresh out of post-secondary education and full of optimism about starting your career, and then you hear the words: 'You have cancer." You are suddenly faced with an unexpected health shock that not only threatens your physical health, but also your financial future. Most of your time is now spent feeling unwell and travelling to and from the hospital for treatment, while your friends and colleagues continue to build their careers.
This is the reality for nearly 1.2 million adolescents and young adults diagnosed with cancer each year worldwide, a number that is projected to rise. Just over 9,000 Canadian adolescents and young adults are diagnosed with cancer annually, and 85 per cent of them will survive their illness.
It is estimated that the average Canadian affected by cancer faces USD 33,000 in lifetime costs related to their illness, totalling USD 7.5 billion each year for patients and their families.
But we have recently discovered that the true economic impact on adolescents and young adults with cancer is often far greater than the previous numbers show and lasts much longer than previously recognised.
The financial penalty of survival We compared 93,325 Canadian adolescents and young adults diagnosed with cancer and 765,240 similar individuals who did not experience cancer, and found that surviving cancer leads to long-term reduced income, which may last a lifetime.
On average, a cancer diagnosis results in a greater than five per cent reduction in earnings over 10 years after diagnosis.
As expected, income loss is more pronounced right after diagnosis, with survivors earning 10 to 15 per cent less in the first five years.
However, these hidden survival costs are not the same for everyone, and the financial toll varies greatly depending on the type of cancer. For instance, survivors of brain cancer see their average annual income drop by more than 25 per cent. This is a devastating financial burden — and one that endures.
The true lifetime effects are unknown, but it is not difficult to imagine how a financial setback like this can completely derail a young person's financial future.
Why cancer costs young survivors more Adolescents and young adults who are survivors of cancer experience 'financial toxicity," which refers to the direct costs of cancer, such as treatment or medication costs, and indirect costs like reduced work ability, extended sick leave and job loss.
Over one-third of young cancer patients report financial toxicity.
Many cancer survivors experience lasting adverse physical and cognitive effects that limit everyday functioning.
Even in the Canadian universal health-care system, which does not require payment for cancer treatment, many younger Canadians are unable to work and need to rely on family members for financial support.
The impact on work capacity is significant for adolescents and young adults who are just beginning their careers, causing them to miss critical years of career development during treatment and recovery that can have cascading economic effects.
These challenges can ultimately lead to financial instability and hardship.
Paying the price Beyond the individual hardships, the issue of financial instability among young cancer survivors is becoming a broader societal challenge.
In 2025, young Canadian cancer survivors are entering an economy with an unfavourable job market and rising youth unemployment, as well as a widening gap between wages and housing affordability. Rising inflation and general unaffordability are also compounding the financial difficulties young Canadian cancer survivors face, ultimately making financial recovery more challenging.
Income is a fundamental social determinant of health, and financial inequities can perpetuate health disparities in cancer survivors after treatment.
Patients are forced into making devastating financial choices like depleting their savings and incurring debt.
Policy A Canadian Cancer Society 2024 report highlights the urgency for support systems to address financial well-being after cancer.
Based on our research, which assesses the financial life of adolescent and young adult survivors of cancer, we have some recommendations for Canadian policymakers, businesses and primary care providers.
Policymakers should: – Make employment insurance benefits that better support survivors post-treatment.
– Provide tax credits for groups of cancer survivors disproportionately affected by financial toxicity, such as those with brain cancer.
Primary care providers should: – Incorporate financial navigation counselling into their cancer care.
– Provide resources for navigating insurance and financial assistance programs.
– Routinely screen for financial toxicity as part of survivorship care.
Employers should: – Create a supportive work environment that accommodates the unique needs of cancer survivors.
– Recognise the physical and mental challenges faced by young survivors and provide flexible work arrangements.
– Young cancer survivors have already faced one of life's most difficult challenges. They shouldn't have to struggle with financial insecurity.
By recognising that survivorship starts at cancer diagnosis, we must broaden the conversation about cancer care beyond the clinical to the economic. (The Conversation) SKS GRS GRS
(This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments
First Published:
August 17, 2025, 13:00 IST
News agency-feeds Hidden costs of cancer for young survivors is derailing their financial futures
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What does the U.S. slashing of funding for mRNA vaccine research mean for public health
What does the U.S. slashing of funding for mRNA vaccine research mean for public health

The Hindu

time11 hours ago

  • The Hindu

What does the U.S. slashing of funding for mRNA vaccine research mean for public health

The United States Department of Health and Human Services recently announced that it would cancel nearly USD 500 million of funding for mRNA vaccine projects. The reason, Health Secretary Robert F. Kennedy Jr. said, was safety and efficacy concerns. mRNA or messenger RNA vaccines hit the news during the Covid-19 pandemic when the world was desperately trying to create vaccines in order to save lives. mRNA vaccines for Covid were developed rapidly, given to thousands of people and are believed to have saved numerous lives. Like all vaccines that we have today, rare cases of adverse effects are possible – but the benefits, say experts far outweigh the risks. How are mRNA vaccines different from the others we have? How effective and safe are they? Can they help with other diseases as well? And what does the cut in funding mean for vaccine development and research worldwide? Guest: Dr Anurag Agrawal, Dean, BioSciences and Health Research, Trivedi School of Biosciences at Ashoka University Host: Zubeda Hamid Edited by Sharmada Venkatasubramanian Listen to more In Focus podcasts:

KPL receives nod to sell its anti-cancer drug Bleomycin 15 IU in Mexico
KPL receives nod to sell its anti-cancer drug Bleomycin 15 IU in Mexico

Business Standard

time14 hours ago

  • Business Standard

KPL receives nod to sell its anti-cancer drug Bleomycin 15 IU in Mexico

Kwality Pharmaceutical has received registration for Bleomycin 15 IU in Mexico for sale and distribution. Bleomycin is a widely used anti-cancer medicine, effective in the treatment of Hodgkin's lymphoma, testicular cancer, and certain squamous cell carcinomas. The company said, "This approval further strengthens our expansion into highly regulated markets, reinforcing our commitment to delivering quality oncology products globally." The projected business potential is around 1 million USD in the first year, and supplies will commence before the end of Q2FY26

China's 2026 humanoid robot pregnancy with artificial womb: A revolutionary leap in reproductive technology
China's 2026 humanoid robot pregnancy with artificial womb: A revolutionary leap in reproductive technology

Time of India

time15 hours ago

  • Time of India

China's 2026 humanoid robot pregnancy with artificial womb: A revolutionary leap in reproductive technology

What if robots could give birth? That future is closer than you think. In a bold announcement at the 2025 World Robot Conference in Beijing, Dr. Zhang Qifeng, founder of Kaiwa Technology, unveiled plans for a humanoid robot pregnancy system powered by an artificial to debut a working prototype in 2026, this breakthrough could transform infertility treatments, reproductive medicine, and even scientific research. The robot's artificial womb mimics a real pregnancy, complete with synthetic amniotic fluid and a nutrient delivery system that supports fetal development from conception to birth. According to the New York Post, this next-gen innovation aims to do more than just replicate biology, it could revolutionize how we define parenthood, offering hope to those unable to conceive and raising deep ethical questions worldwide. As China pushes the boundaries of science and robotics, the world stands at the edge of a new era where machines might not just build our future, but give life to it. Artificial womb in humanoid robot pregnancy: Simulating the complete gestation process At the heart of the humanoid robot pregnancy system lies a groundbreaking artificial womb, engineered to replicate the functions of a human uterus with remarkable precision. This advanced system delivers nutrients, oxygen, and temperature regulation, creating an optimal environment to support fetal development through a full 10-month gestation. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Writing in English Doesn't Have to Feel Hard Grammarly Learn More Undo According to Dr. Zhang Qifeng, the womb is fully integrated into the robot's body and capable of managing every stage from fertilization and implantation to full-term pregnancy. Beyond its reproductive potential, the technology opens new frontiers in medical research, offering scientists an unprecedented opportunity to study pregnancy complications, genetic disorders, and maternal-fetal interactions in a controlled, observable setting. This level of access and control has never before been possible in natural human gestation. Humanoid robot pregnancy prototype launch and cost Dr. Zhang confirmed that the first prototype of the humanoid robot pregnancy system will be unveiled in 2026. Priced at around 100,000 yuan (approximately $13,900 USD), this innovation could become a more affordable alternative to traditional surrogacy, which often comes with high costs and complex legal challenges. By making this technology accessible, millions of couples struggling with infertility might finally find a new path to parenthood. Beyond affordability, the system promises to ease the physical and emotional burdens that pregnancy can place on human mothers, offering a safer and less stressful experience. This breakthrough could not only change the future of reproductive medicine but also redefine what it means to carry and nurture new life. Ethical and legal considerations of humanoid robot pregnancy While the technology promises transformative benefits, it also raises complex ethical and legal questions. Dr. Zhang highlighted ongoing discussions with Guangdong authorities regarding regulation and policy frameworks. Important debates include the definition of parenthood, the rights of a child born via robotic gestation, and broader societal implications. Clear legal and ethical guidelines will be essential to ensure that humanoid robot pregnancy technology is applied responsibly. Potential applications and societal impact of humanoid robot pregnancy Humanoid robot pregnancy could revolutionize infertility solutions, offering an alternative to traditional surrogacy. Beyond personal reproduction, it may serve as a valuable research tool, enabling scientists to observe fetal development and pregnancy in controlled conditions. The societal impact of widespread adoption could be profound, potentially influencing family structures, reproductive rights, and global medical practices. Ethical oversight and public dialogue will be crucial as the technology develops. China's humanoid robot pregnancy system, featuring a fully integrated artificial womb, represents a groundbreaking step in reproductive medicine, robotics, and artificial intelligence. The official announcement by Dr. Zhang Qifeng has positioned this project at the forefront of global innovation. As the prototype approaches its 2026 launch, ongoing discussion around ethical, legal, and societal implications will be vital to ensure that this revolutionary technology benefits humanity responsibly. Also read| Eating 60 grams of almonds daily can protect DNA and reduce oxidative stress: Study

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store